Condition

Neuroblastoma

ClinicalTrials.gov condition label

Clinical trials34
Recruiting4
Common interventions25
Lead sponsors shown15

Clinical trials

34 shown
Biomarkers of Resiliency In Childhood Cancer SurgeryNCT06674811 · 2025-01-15
RECRUITING
Agnostic Therapy in Rare Solid TumorsNCT06638931 · 2024-07-16
RECRUITING
18F-DOPA II - PET Imaging OptimizationNCT04706910 · 2021-01-20
RECRUITING
Familial Investigations of Childhood Cancer PredispositionNCT03050268 · 2017-04-06
RECRUITING
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.NCT07595666 · 2025-09-30
ENROLLING_BY_INVITATION
Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid TumorNCT04864821 · 2021-05-14
UNKNOWN
Dynamic Whole Body Positron Emission Tomography/Computed Tomography ImagingNCT04017104 · 2019-11-01
UNKNOWN
DOTATOC PET/CT for Imaging NET PatientsNCT03583528 · 2018-07-11
ACTIVE_NOT_RECRUITING
18F-DOPA PET Imaging: an Evaluation of Biodistribution and SafetyNCT03042416 · 2017-06-29
COMPLETED
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesNCT02457650 · 2015-04-01
UNKNOWN
Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical ImagingNCT01482741 · 2011-11-01
COMPLETED
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic SyndromeNCT00946283 · 2010-03-01
TERMINATED
Genomic Structural Variation in Cancer SusceptibilityNCT00996710 · 2009-10-01
ACTIVE_NOT_RECRUITING
Blood Samples From Patients on a Clinical Trial to CINV During HSCTNCT00900068 · 2008-08-01
TERMINATED
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell TransplantNCT00602446 · 2007-08-01
TERMINATED
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell TransplantNCT00900406 · 2007-01-01
COMPLETED
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantNCT00651716 · 2006-12-01
TERMINATED
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantNCT00410657 · 2006-07-01
COMPLETED
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantNCT00324324 · 2006-05-01
TERMINATED
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerNCT00445965 · 2006-01-01
COMPLETED
Campath-1H + FK506 and Methylprednisolone for GVHDNCT00109993 · 2005-01-01
COMPLETED
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantNCT00293384 · 2004-10-01
COMPLETED
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationNCT00064311 · 2003-06-01
COMPLETED
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation PatientsNCT00082654 · 2002-03-01
COMPLETED
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid TumorsNCT00004157 · 2000-08-01
COMPLETED
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonNCT00010283 · 2000-07-01
COMPLETED
Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed NeuroblastomaNCT00025623 · 1999-07-01
COMPLETED
Combination Chemotherapy in Treating Infants With Newly Diagnosed NeuroblastomaNCT00025610 · 1999-07-01
COMPLETED
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationNCT00003887 · 1998-08-01
COMPLETED
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerNCT00003408 · 1998-04-01
COMPLETED
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectNCT00003425 · 1997-12-01
COMPLETED
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsNCT00003107 · 1997-10-01
COMPLETED
Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerNCT00003022 · 1997-04-01
COMPLETED
Prevalence+Significance of Paraneoplastic Autoantibodies in Many CancersNCT00608452 · 1995-07-01
COMPLETED

Common interventions

CyclophosphamideDRUG5flow cytometryOTHER3immunologic techniqueOTHER3laboratory biomarker analysisOTHER318F-DOPADRUG218F-FDG PET/CTDIAGNOSTIC_TEST268Ga-DOTATOC PET/CTDIAGNOSTIC_TEST2alemtuzumabBIOLOGICAL2carboplatinDRUG2doxorubicin hydrochlorideDRUG2etoposideDRUG2filgrastimBIOLOGICAL2iodine I 131 monoclonal antibody 3F8RADIATION2methylprednisoloneDRUG2pharmacological studyOTHER2vincristine sulfateDRUG2131I-3F8RADIATION118F-DCFPyL PET/CTDIAGNOSTIC_TEST1aldesleukinBIOLOGICAL1amifostine trihydrateDRUG1Anti-NY ESO-1 TCR-transduced T cellsBIOLOGICAL1AprepitantDRUG1beclomethasone dipropionateDRUG1biopsyPROCEDURE1Blood DrawOTHER1

Leading sponsors

Fred Hutchinson Cancer Center5Memorial Sloan Kettering Cancer Center5British Columbia Cancer Agency2European Infant Neuroblastoma Study Group - 19992OHSU Knight Cancer Institute2University of Alberta2Vanderbilt-Ingram Cancer Center2Barbara Ann Karmanos Cancer Institute1Cancer Treatment Centers of America1Case Comprehensive Cancer Center1Indiana University1Instituto do Cancer do Estado de São Paulo1Masonic Cancer Center, University of Minnesota1Mayo Clinic1National Institutes of Health Clinical Center (CC)1

Trial status mix

COMPLETED19
TERMINATED5
RECRUITING4
UNKNOWN3
ACTIVE_NOT_RECRUITING2
ENROLLING_BY_INVITATION1

Phase mix

PHASE213
PHASE16
NA4
PHASE33
EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.